Nicola Vousden and colleagues have found that in the UK, out of 3,371 pregnant women who have been hospitalized with symptomatic COVID-19, 24% of admitted women infected with the Wild type SARS-CoV-2 had moderate or severe disease, compared to 36% with the Alpha variant and 45% with the Delta variant. Therefore, it could be said that pregnant women are up to twice as likely to develop severe symptoms when acquiring the infection of mutated SARS-CoV-2 which are able to neutralize the protection generated by FA supplements.